One year experience with erenumab: real-life data in 30 consecutive patients

Neurol Sci. 2020 Dec;41(Suppl 2):505-506. doi: 10.1007/s10072-020-04677-y.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Calcitonin Gene-Related Peptide Receptor Antagonists*
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Calcitonin Gene-Related Peptide Receptor Antagonists
  • erenumab